See also this year's filing and all EDGAR filings for this company.
PDF Report 0001516551_2020_Skye_Bioscience_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001516551, Skye Bioscience Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 1,994,760 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,983 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 970,818 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 477,867 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 4,411,629 |
| 9 | ResearchAndDevelopmentExpense | 2,243,111 |
| 10 | remainder_Expenses | 3,802,889 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -7,891,591 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 1,996,743 |
| 1 | Liabilities | 1,448,685 |
| 2 | Expenses | 10,457,629 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 548,058 |
| 5 | NetIncome | -18,349,220 |
| 6 | ComprehensiveNetIncome | -18,349,220 |
| 7 | BaseVar | 10,897,324 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -9.96 |
| 9 | EconomicCapitalRatio | 0.000506 |
Edgar->Model Mapping
Feature Distribution
Change over Time
